secwatch.observer — SEC 8-K summary
======================================

Issuer:     VACCINEX, INC. (VCNX)
CIK:        0001205922
Form:       8-K
Filed at:   2024-02-13T23:59:59+00:00
Accession:  0001193125-24-033801
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Vaccinex shareholders approve reverse stock split at ratio of 1:4 to 1:14
-------------------------------------------------------------------------

- Approved by 7,075,432 votes for, 258,830 against, 37,142 abstain.
- Board authorized to implement reverse split at any ratio between 1-for-4 and 1-for-14.
- Action likely intended to regain compliance with Nasdaq minimum bid price requirement.
- Exact ratio and timing to be determined by Board at its discretion.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1205922/000119312524033801/0001193125-24-033801-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1205922/000119312524033801/d785029d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-033801

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer